Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

xockdown

UK lockdown caused infection ‘R’ rate to drop as low as 0.57, according to a new study

July 15, 2020 Research and Development COVID, COVID-19, Lockdown, coronavirus

A new study showed that the coronavirus infection rate hit its lowest point one month before lockdown restrictions were lifted. …
News
fdaoutsideweb

FDA committee backs GSK’s belantamab mafodotin in relapsed or refractory multiple myeloma

July 15, 2020 Research and Development, Sales and Marketing Cancer, FDA, GSK, multiple myeloma, pharma

The FDA’s Oncologic Drugs Advisory Committee (ODAC) has moved to recommend the use of GlaxoSmithKline’s belantamab mafodotin, or GSK2857916 as …
News
vaxx

Moderna’s COVID-19 vaccine candidate set for final testing in the US

July 15, 2020 Research and Development COVID-19, coronavirus

The first COVID-19 vaccine being used in clinical trials in the US is set to begin final testing. The experimental …
News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

July 15, 2020 Research and Development COVID-19, coronavirus, vaccines

The coronavirus news this week focuses on therapeutics, with Gilead’s remdesivir reducing the risk of death in 62% of severe …
News
shutter

Malaria prophylactic tafenoquine shows antiviral activity against SARS-CoV-2 in cell cultures

July 14, 2020 Manufacturing and Production, Research and Development 60 Degrees Pharmaceuticals, COVID-19, coronavirus, pharma

Specialist tropical disease drug firm 60 Degrees Pharmaceuticals has revealed that its therapy Arakoda (tafenoquine) has been shown in cell …
News
shutterstock_273326141

Roche and Blueprint extend collaboration with $1.7 billion cancer drug development and commercialisation deal

July 14, 2020 Manufacturing and Production, Research and Development Blueprint Medicines, Cancer, Roche, pralsetinib

Roche and Blueprint Medicines have come together in a $1.7 billion development and commercialisation partnership focused on precision therapy pralsetinib …
News
pfizer_finland_hq_february_13_2009_1

Pfizer and BioNTech’s COVID-19 vaccines to have their development fast tracked by the FDA

July 14, 2020 Manufacturing and Production, Research and Development COVID-19, Vaccine, coronavirus

The FDA has granted Pfizer and BioNTech’s COVID-19 vaccine candidates Fast Track status to speed up their development and review. …
News
shutterstock_38078521

Itolizumab “significantly reduced mortality” in hospitalised COVID-19 patients with respiratory distress, secures emergency use authorisation in India

July 13, 2020 Research and Development, Sales and Marketing COVID-19, Itolizumab, coronavirus

Itolizumab, a drug currently being developed by biotech firm Equillium for autoimmune and inflammatory disorders, “significantly reduced mortality” in hospitalised …
News
tecentriq

Roche’s Tecentriq fails to hit main Phase 3 goal in front-line ovarian cancer

July 13, 2020 Research and Development, Sales and Marketing Genentech, Roche, ovarian cancer, tecentriq

Roche subsidiary Genentech has revealed that its immunotherapy Tecentriq (atezolizumab), combined with Avastin (bevacizumab), paclitaxel and carboplatin, fell short of …
News
edwin

Dr Edwin Moses appointed as Chairman of the Board of Sensorin

July 10, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Sensorin have appointed Dr Edwin Moses as the Chairman of its Board of Directors Moses joins from his previous role …
Appointment
shutterstock_159488225

New data shows Gilead’s remdesivir “potently inhibited” SARS-CoV-2 in human lung cell cultures

July 10, 2020 Medical Communications, Research and Development COVID-19, Gilead, coronavirus, remdesivir

New findings published from researchers at Vanderbilt University Medical Center (VUMC) at the University of North Carolina, as well as …
News
shutterstock_gonnorrhea

Industry comes together to form the AMR Action Fund, pledging $1bn to fight antimicrobial resistance

July 10, 2020 Medical Communications, Research and Development AMR, antimicrobial resistance, biotech, pharma

Over 20 biopharma firms have come together to launch the AMR Action Fund, an initiative of the International Federation of …
News
european_commission_web

European green light for Lynparza in germline BRCA-mutated metastatic pancreatic cancer

July 8, 2020 Research and Development, Sales and Marketing AstraZeneca, Cancer, Europe, MSD, lynparza

The European Commission has awarded approval to AstraZeneca and MSD’s Lynparza (olaparib) for germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer, with …
News
shutterstock_3

COVID-19 impact on England’s cancer services could lead to 35,000 excess deaths

July 8, 2020 Research and Development COVID-19, Cancer, England, coronavirus

New data emerging from DATA-CAN: The Health Data Research Hub for Cancer has shone a light on the potential toll …
News
trummy

Trump moves to formally remove the US from the World Health Organization

July 8, 2020 Research and Development COVID-19, Trump, WHO

President Donald Trump has formally moved to end the US membership of the World Health Organization. He has notified both …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026